L-CAREBEX 50-20

MRP

MRP 405/-UNIT

Description

• Composition :Each Actuation Delivers : Levosalbutamol Sulphate IP Equivalent to Levosalbutamol 50mcg + Ipratropium Bromide IP equivalent to Ipratropium anhydrous 20mcg Suspended In propellent HFA 134a q.s.

Doses

• As directed by the Physician

Indication

• Levosalbutamol & Ipratropium Bromide inhalers are primarily indicated for managing Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema, by relaxing airway muscles to relieve symptoms like wheezing, coughing, and shortness of breath.